TheraGenetics Ltd, a spinout from the Institute of Psychiatry at King's College in London in April 2006, hopes to have its gene-based diagnostic tests ready in about two years, its chief executive, Richard Kivel, said.
Novartis AG is seeking to get a decision by India’s Patent Office overturned by the country’s Intellectual Property Appellate Board (IPAB) despite losing a separate appeal in the High Court.
A new European guideline outlining how companies and regulators can identify and mitigate risks associated with the first studies in humans of novel medicinal products is due to take effect on 1 September 2007.
The UK government has decided to change its 50-year old system for indirectly setting the price of drugs sold to the National Health Service (NHS).
Shares of GPC Biotech AG have begun to recover after the company announced that it was withdrawing its New Drug Application (NDA) with the US Food and Drug Administration (FDA) for accelerated approval of its cancer-drug candidate, satraplatin.
A joint committee of the UK Parliament is supporting the creation and use of hybrid, human-animal embryos for research provided they are destroyed within 14 days after fertilisation and they are not implanted in a womb, according to the committee’s chairman, Phil Willis, the Liberal Democrat MP for Harrogate and Knaresborough.
Over the past 19 months, some 272 small enterprises have approached the European Medicines Agency (EMEA) to ask for assistance in carrying out their development and registration programmes, according to new figures from the agency.
Kinaxo Biotechnologies GmbH has received a grant of about €1 million from Germany’s Ministry of Education and Research (BMBF) to develop a new way of quantifying small molecule-protein interactions by combining mass spectrometry with Kinaxo’s chemical proteomics technology platform, KinaTor.
Germany’s Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung) has disclosed that it will make more than €400 million available for grants to the life sciences in 2008, representing an increase of €46 million or 13% from its budget for 2007.
The European Commission is asking scientists, industrialists and members of the public to help it draft a code of conduct for nanotechnology.